279 related articles for article (PubMed ID: 23685353)
1. High-shear granulation as a manufacturing method for cocrystal granules.
Rehder S; Christensen NP; Rantanen J; Rades T; Leopold CS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1019-30. PubMed ID: 23685353
[TBL] [Abstract][Full Text] [Related]
2. Formation of Indomethacin-Saccharin Cocrystals during Wet Granulation: Role of Polymeric Excipients.
Tanaka R; Duggirala NK; Hattori Y; Otsuka M; Suryanarayanan R
Mol Pharm; 2020 Jan; 17(1):274-283. PubMed ID: 31756100
[TBL] [Abstract][Full Text] [Related]
3. Manipulating theophylline monohydrate formation during high-shear wet granulation through improved understanding of the role of pharmaceutical excipients.
Wikström H; Carroll WJ; Taylor LS
Pharm Res; 2008 Apr; 25(4):923-35. PubMed ID: 17896097
[TBL] [Abstract][Full Text] [Related]
4. Kinetics Study of Cocrystal Formation Between Indomethacin and Saccharin Using High-Shear Granulation With In Situ Raman Spectroscopy.
Tanaka R; Hattori Y; Ashizawa K; Otsuka M
J Pharm Sci; 2019 Oct; 108(10):3201-3208. PubMed ID: 31279736
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of drug physical form during granulation, tabletting and storage.
Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
[TBL] [Abstract][Full Text] [Related]
6. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
[TBL] [Abstract][Full Text] [Related]
7. Switching from batch to continuous granulation: A case study of metoprolol succinate ER tablets.
Kotamarthy L; Feng X; Alayoubi A; Kumar Bolla P; Ramachandran R; Ashraf M; O'Connor T; Zidan A
Int J Pharm; 2022 Apr; 617():121598. PubMed ID: 35202728
[TBL] [Abstract][Full Text] [Related]
8. Twin screw granulation as a simple and efficient tool for continuous wet granulation.
Keleb EI; Vermeire A; Vervaet C; Remon JP
Int J Pharm; 2004 Apr; 273(1-2):183-94. PubMed ID: 15010142
[TBL] [Abstract][Full Text] [Related]
9. Evaluating scale-up rules of a high-shear wet granulation process.
Tao J; Pandey P; Bindra DS; Gao JZ; Narang AS
J Pharm Sci; 2015 Jul; 104(7):2323-33. PubMed ID: 26010137
[TBL] [Abstract][Full Text] [Related]
10. New gentle-wing high-shear granulator: impact of processing variables on granules and tablets characteristics of high-drug loading formulation using design of experiment approach.
Fayed MH; Abdel-Rahman SI; Alanazi FK; Ahmed MO; Tawfeek HM; Al-Shdefat RI
Drug Dev Ind Pharm; 2017 Oct; 43(10):1584-1600. PubMed ID: 28480773
[TBL] [Abstract][Full Text] [Related]
11. Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets.
Tantry JS; Tank J; Suryanarayanan R
J Pharm Sci; 2007 May; 96(5):1434-44. PubMed ID: 17455350
[TBL] [Abstract][Full Text] [Related]
12. Dextrose monohydrate as a non-animal sourced alternative diluent in high shear wet granulation tablet formulations.
Mitra B; Wolfe C; Wu SJ
Drug Dev Ind Pharm; 2018 May; 44(5):817-828. PubMed ID: 29300107
[TBL] [Abstract][Full Text] [Related]
13. Prediction of quality attributes (mechanical strength, disintegration behavior and drug release) of tablets on the basis of characteristics of granules prepared by high shear wet granulation.
Khan A
PLoS One; 2021; 16(12):e0261051. PubMed ID: 34882723
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical production of tableting granules in an ultra-small-scale high-shear granulator as a pre-formulation study.
Ogawa T; Uchino T; Takahashi D; Izumi T; Otsuka M
Drug Dev Ind Pharm; 2012 Nov; 38(11):1390-3. PubMed ID: 22356186
[TBL] [Abstract][Full Text] [Related]
15. Formulation of a poorly water-soluble drug in sustained-release hollow granules with a high viscosity water-soluble polymer using a fluidized bed rotor granulator.
Asada T; Yoshihara N; Ochiai Y; Kimura SI; Iwao Y; Itai S
Int J Pharm; 2018 Apr; 541(1-2):246-252. PubMed ID: 29496456
[TBL] [Abstract][Full Text] [Related]
16. Evolution of structure and properties of granules containing microcrystalline cellulose and polyvinylpyrrolidone during high-shear wet granulation.
Osei-Yeboah F; Feng Y; Sun CC
J Pharm Sci; 2014 Jan; 103(1):207-15. PubMed ID: 24218097
[TBL] [Abstract][Full Text] [Related]
17. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.
Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604
[TBL] [Abstract][Full Text] [Related]
18. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
[TBL] [Abstract][Full Text] [Related]
19. Challenges in Transitioning Cocrystals from Bench to Bedside: Dissociation in Prototype Drug Product Environment.
Koranne S; Sahoo A; Krzyzaniak JF; Luthra S; Arora KK; Suryanarayanan R
Mol Pharm; 2018 Aug; 15(8):3297-3307. PubMed ID: 29947519
[TBL] [Abstract][Full Text] [Related]
20. A large-scale experimental comparison of batch and continuous technologies in pharmaceutical tablet manufacturing using ethenzamide.
Matsunami K; Nagato T; Hasegawa K; Sugiyama H
Int J Pharm; 2019 Mar; 559():210-219. PubMed ID: 30682448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
